Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYR61 |
| Upstream (Parents) |
|---|
| (<<) ACTA2 → CYR61 |
| (<<) CDH11 → CYR61 |
| (<<) EFEMP1 → CYR61 |
| (<<) ISLR → CYR61 |
| (<<) MSN → CYR61 |
| (<<) MYL9 → CYR61 |
| (<<) PTRF → CYR61 |
| (<<) TIMP2 → CYR61 |
| (<<) VEGFC → CYR61 |
| (<<) VIM → CYR61 |
| Downstream (Children) |
|---|
| CYR61 → ACTN1 (>>) |
| CYR61 → ATP7B (>>) |
| CYR61 → CHST3 (>>) |
| CYR61 → CTGF (>>) |
| CYR61 → DUSP9 (>>) |
| CYR61 → ERBB3 (>>) |
| CYR61 → HSPA2 (>>) |
| CYR61 → IL6 (>>) |
| CYR61 → ITGA5 (>>) |
| CYR61 → ITGAV (>>) |
| CYR61 → MMP14 (>>) |
| CYR61 → PIK3CG (>>) |
| CYR61 → PRKACA (>>) |
| CYR61 → RHOQ (>>) |
| CYR61 → THBS1 (>>) |
| CYR61 → TIMP1 (>>) |
